Most GLP-1 pricing on the internet is a riddle: an advertised membership here, a "from" price there, and the real monthly number buried in an FAQ. This page is the opposite. Below are the actual pharmacy pass-through prices for branded, FDA-approved GLP-1 medications on the GoodLife Health platform — every dose, billed by the pharmacy, with no markup from anyone.
- Injectable Wegovy runs $270.40 at starting doses (0.25mg, 0.5mg) and $420.40 at 1mg and above at pharmacy pass-through.
- Zepbound runs $370.40 at the 2.5mg starting dose, $470.40 at 5mg, and $520.40 from 7.5mg through 15mg.
- Oral options are the new price floor: Wegovy Tablets from $220.40 and Foundayo (orforglipron) from $220.40 per month.
- Zepbound and Mounjaro are the same molecule (tirzepatide); cash-pay patients are routed to Zepbound because Mounjaro's cash price is roughly double.
- These prices are the medication only. The GoodLife Health membership is a separate flat $299/month covering the clinical relationship and quarterly Biomarker Audits — it never changes with molecule or dose.
The full pass-through price list
Branded GLP-1 pass-through prices
Billed by the pharmacy; no markup, no molecule or dose upcharge
| Medication | Dose | Pass-through price/month |
|---|---|---|
| Wegovy (semaglutide) | 0.25mg, 0.5mg | $270.40 |
| Wegovy (semaglutide) | 1mg, 1.7mg, 2.4mg | $420.40 |
| Ozempic (semaglutide) | 0.25mg | $270.40 |
| Ozempic (semaglutide) | 0.5mg, 1mg | $420.40 |
| Ozempic (semaglutide) | 2mg | $570.40 |
| Zepbound (tirzepatide) | 2.5mg | $370.40 |
| Zepbound (tirzepatide) | 5mg | $470.40 |
| Zepbound (tirzepatide) | 7.5mg–15mg | $520.40 |
| Wegovy Tablets (oral semaglutide) | 1.5mg, 4mg | $220.40 |
| Wegovy Tablets (oral semaglutide) | 9mg, 25mg | $370.40 |
| Foundayo (orforglipron, oral) | 0.8mg | $220.40 |
| Foundayo (orforglipron, oral) | 2.5mg | $270.40 |
| Foundayo (orforglipron, oral) | 5.5mg–17.2mg | $370.40 |
For context: U.S. list prices for injectable GLP-1s run roughly $1,000 to $1,350 a month before discounts, and manufacturer direct-pay programs typically land around $349 to $499. Pass-through pricing at or below the manufacturer channel, with a full clinical relationship attached, is the point of the model.
The Zepbound vs Mounjaro routing rule
Zepbound and Mounjaro are the same molecule — tirzepatide, made by Eli Lilly — with different labels. Mounjaro carries the type 2 diabetes label and a cash pass-through price near $970 a month; Zepbound carries the weight-management label at $370 to $520. The clinical routing follows directly: cash-pay patients are prescribed Zepbound, and Mounjaro is reserved for patients whose insurance covers it for type 2 diabetes, where prior authorization support applies. A platform earning margin on the drug has little reason to volunteer this. A zero-markup platform has no reason not to.
What these prices do not include, on purpose
The prices above are the medication alone, billed by the pharmacy. The clinical work — comprehensive Biomarker Audits every 90 days, contraindication screening, dose titration, side-effect management, and hormone optimization when indicated — is the GoodLife Health membership at a flat $299/month. The two numbers never blend, which is what keeps both of them honest. All-in math for common scenarios is worked through in the true monthly cost of GLP-1 telehealth.
GoodLife Health prescribes branded, FDA-approved GLP-1 medications only. It does not facilitate compounded semaglutide or tirzepatide under any circumstance.
FAQ
What does Wegovy cost without insurance at pass-through? $270.40 a month at the 0.25mg and 0.5mg starting doses, and $420.40 at 1mg, 1.7mg, and 2.4mg, billed by the pharmacy with no markup on the GoodLife Health platform.
What does Zepbound cost at pass-through? $370.40 at 2.5mg, $470.40 at 5mg, and $520.40 from 7.5mg through the 15mg maintenance dose.
Why is Mounjaro so much more expensive than Zepbound? They are the same molecule with different labels. Mounjaro's type 2 diabetes label carries a cash price near $970 a month, so cash-pay weight-management patients are routed to Zepbound and Mounjaro is reserved for insurance-covered diabetes treatment.
Are there oral GLP-1 options? Yes — Wegovy Tablets (oral semaglutide) from $220.40 and Foundayo (orforglipron) from $220.40 a month at pass-through, both branded and FDA-approved.
Does the GoodLife Health fee change with my medication? Never. The membership is a flat $299/month regardless of molecule or dose. Medication is billed separately by the pharmacy at the prices listed here.
Related guides
- The true monthly cost of GLP-1 telehealth
- The GLP-1 dose-escalation trap
- Oral GLP-1s: Foundayo and Wegovy Tablets explained
- Medical Weight Loss at GoodLife Health
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/